Literature DB >> 20814212

Pancreatic cancer: epidemiology and risk factors.

Guenter J Krejs1.   

Abstract

Ductal adenocarcinoma of the pancreas has an incidence of approximately 10 per 100,000 population per year. This number pertains to Europe, North America and parts of South America (Argentina). Men are more often afflicted than women (female:male ratio of about 1:1.5, though reports vary). There has been a very small but steady increase in the incidence over the last 50 years. Unfortunately, numbers for incidence and mortality are still practically identical for this cancer. The peak of incidence is between 60 and 80 years of age. In absolute numbers, there are 8,000 cases diagnosed annually in Germany, and 33,000 in the US. Pancreatic cancer at <40 years of age is extremely rare (2 cases per million per year), but among 80-year-olds, the incidence is about 200 new cases per 100,000 population per year. In men, carcinoma of the pancreas is the fourth most common cause of cancer death after lung, prostate and colorectal cancer. In women, it is the fifth most common cause of cancer death. Risk factors for pancreatic cancer include high-fat diet, smoking, chronic pancreatitis, primary sclerosing cholangitis, hereditary pancreatitis, family history of pancreatic cancer and diabetes mellitus. In chronic pancreatitis, the risk for pancreatic cancer is increased 20-fold, in hereditary pancreatitis it is 60-fold higher than in the general population. In a kindred with 2 first-degree relatives with pancreatic cancer, the risk for pancreatic cancer for other members of that kindred is 7-fold higher. Copyright (c) 2010 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2010        PMID: 20814212     DOI: 10.1159/000319414

Source DB:  PubMed          Journal:  Dig Dis        ISSN: 0257-2753            Impact factor:   2.404


  42 in total

1.  Association of single nucleotide polymorphisms of DNA repair genes in NER pathway and susceptibility to pancreatic cancer.

Authors:  Fuli Zhao; Yuhong Shang; Chen Zeng; Dongdong Gao; Ke Li
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

Review 2.  Cancer stem cells: involvement in pancreatic cancer pathogenesis and perspectives on cancer therapeutics.

Authors:  Cristiana Pistol Tanase; Ana Iulia Neagu; Laura Georgiana Necula; Cristina Mambet; Ana-Maria Enciu; Bogdan Calenic; Maria Linda Cruceru; Radu Albulescu
Journal:  World J Gastroenterol       Date:  2014-08-21       Impact factor: 5.742

Review 3.  Current treatment options for pancreatic carcinoma.

Authors:  Emily Castellanos; Jordan Berlin; Dana Backlund Cardin
Journal:  Curr Oncol Rep       Date:  2011-06       Impact factor: 5.075

Review 4.  Alcoholic pancreatitis: New insights into the pathogenesis and treatment.

Authors:  Dahn L Clemens; Katrina J Schneider; Christopher K Arkfeld; Jaclyn R Grode; Mark A Wells; Shailender Singh
Journal:  World J Gastrointest Pathophysiol       Date:  2016-02-15

5.  Gallstones, a cholecystectomy, chronic pancreatitis, and the risk of subsequent pancreatic cancer in diabetic patients: a population-based cohort study.

Authors:  Hsueh-Chou Lai; I-Ju Tsai; Pei-Chun Chen; Chih-Hsin Muo; Jen-Wei Chou; Cheng-Yuan Peng; Shih-Wei Lai; Fung-Chang Sung; Shu-Yu Lyu; Donald E Morisky
Journal:  J Gastroenterol       Date:  2012-10-03       Impact factor: 7.527

6.  Targeted therapies for pancreatic adenocarcinoma: Where do we stand, how far can we go?

Authors:  Dimitra Grapsa; Muhammad Wasif Saif; Konstantinos Syrigos
Journal:  World J Gastrointest Oncol       Date:  2015-10-15

7.  E-cadherin expression in obesity-associated, Kras-initiated pancreatic ductal adenocarcinoma in mice.

Authors:  Alexander P Stark; Hui-Hua Chang; Xiaoman Jung; Aune Moro; Kathleen Hertzer; Mu Xu; Andrea Schmidt; O Joe Hines; Guido Eibl
Journal:  Surgery       Date:  2015-08-18       Impact factor: 3.982

8.  Association between CLPTM1L-TERT rs401681 polymorphism and risk of pancreatic cancer: a meta-analysis.

Authors:  Cheng-Li Liu; Xiao-Xia Zang; Cheng Wang; Ya-Lin Kong; Hui Zhang; Hong-Yi Zhang
Journal:  Clin Exp Med       Date:  2014-10-05       Impact factor: 3.984

9.  Gemcitabine-Related Pneumonitis in Pancreas Adenocarcinoma--An Infrequent Event: Elucidation of Risk Factors and Management Implications.

Authors:  Ibrahim Halil Sahin; Alexander I Geyer; Daniel W Kelly; Eileen Mary O'Reilly
Journal:  Clin Colorectal Cancer       Date:  2015-08-22       Impact factor: 4.481

10.  Chemotherapy-Induced Inflammatory Gene Signature and Protumorigenic Phenotype in Pancreatic CAFs via Stress-Associated MAPK.

Authors:  Paul A Toste; Andrew H Nguyen; Brian E Kadera; Mindy Duong; Nanping Wu; Irmina Gawlas; Linh M Tran; Mihir Bikhchandani; Luyi Li; Sanjeet G Patel; David W Dawson; Timothy R Donahue
Journal:  Mol Cancer Res       Date:  2016-03-15       Impact factor: 5.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.